Dr Himanshu Aggarwal

Dr. Himanshu Aggarwal is a highly experienced rheumatologist with over 19 years of clinical experience in diagnosing and managing complex autoimmune and inflammatory diseases. He has undergone advanced training at premier institutions such as AIIMS, Indraprastha Apollo Hospitals, and EULAR (Europe). His expertise includes managing rheumatoid arthritis, lupus, scleroderma, vasculitis, and other connective tissue diseases. Known for his patient-focused approach, Dr. Aggarwal emphasizes early diagnosis, precise immunological evaluation, and evidence-based treatment for long-term relief and improved quality of life.

Educational Qualifications

• MBBS – University College of Medical Sciences (UCMS) & Guru Teg Bahadur (GTB) Hospital, University of Delhi
• MD (Medicine) – DY Patil Medical College & Hospital, Pune
• DNB (Rheumatology) – Indraprastha Apollo Hospitals, New Delhi
• 3-Year Super Speciality Training (Rheumatology) – Department of Clinical Immunology and Rheumatology, All India Institute of Medical Sciences (AIIMS), New Delhi
• Certified Course (Rheumatic Diseases) – European League Against Rheumatism (EULAR), 2 years
• Short-Term Observership Training (Clinical Immunology) – Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow
• Short-Term Training (Rheumatology and Clinical Immunology) – Army Hospital (Research and Referral), New Delhi

Professional Experience

• Consultant – Rheumatology, Max Healthcare (Present)
• Rheumatology Registrar – Indraprastha Apollo Hospitals, New Delhi
• Senior Resident – Department of Clinical Immunology and Rheumatology, All India Institute of Medical Sciences (AIIMS), New Delhi

Professional Memberships

• Life Member – Indian Rheumatology Association (IRA) (LM-1223)
• Life Member – Delhi Rheumatology Association (DRA)

Research Papers and Publications

• Safety and Efficacy of Abatacept in Patients with DMARDs Refractory Rheumatoid Arthritis – An AIIMS Experience, presented at Indian Rheumatology Association Conference (IRACON), 2012
• An Open-Label Study to Assess the Safety and Efficacy of a Single Intra-Articular Injection of High Molecular Weight Hyaluronic Acid in Patients with Osteoarthritis of the Knee